Integrating Public Health Concerns into Patent Legislation in Developing Countries
(2000; 140 pages) [French] [Spanish] Voir le document au format PDF
Table des matières
Afficher le documentTHE SOUTH CENTRE
Afficher le documentFOREWORD
Afficher le documentACKNOWLEDGEMENTS
Afficher le documentGLOSSARY*
Ouvrir ce répertoire et afficher son contenuI. INTRODUCTION
Fermer ce répertoireII. PATENTABLE SUBJECT MATTER
Afficher le documentII.1 Products
Ouvrir ce répertoire et afficher son contenuII.2 Substances Existing in Nature
Ouvrir ce répertoire et afficher son contenuII.3 Uses
Fermer ce répertoireII.4 Methods for Treatment and Diagnostics
Afficher le documentII.4.1 Options - Methods
Afficher le documentII.5 Traditional Medicines
Ouvrir ce répertoire et afficher son contenuIII. SCOPE OF CLAIMS
Ouvrir ce répertoire et afficher son contenuIV. PATENTABILITY REQUIREMENTS
Ouvrir ce répertoire et afficher son contenuV. SPECIAL CASES IN PHARMACEUTICALS
Ouvrir ce répertoire et afficher son contenuVI. DISCLOSURE
Ouvrir ce répertoire et afficher son contenuVII. EXCEPTIONS TO EXCLUSIVE RIGHTS
Ouvrir ce répertoire et afficher son contenuVIII. EXAMINATION AND OBSERVATION PROCEDURES
Ouvrir ce répertoire et afficher son contenuIX. CLAIMS INTERPRETATION
Ouvrir ce répertoire et afficher son contenuX. COMPULSORY LICENSING
Afficher le documentXI. FINAL REMARKS
Afficher le documentREFERENCES
Afficher le documentBACK COVER
 

II.4.1 Options - Methods

A typical exclusion from patentability, as contained in many laws in force, may contain the following:

Diagnostic, Therapeutical and Surgical Methods
Model Option

Patents shall not be granted in respect of diagnostic, therapeutic and surgical methods for the treatment of humans and animals.

It should be noted that, even in the absence of specific provisions excluding the patentability of the referred methods, they may be deemed non eligible for protection due to the lack of industrial applicability, one of the essential requirements for patentability (see Section IV.3 below).

If the patentability of such methods were, however, admitted by national laws, its implications for the supply of health services should be assessed. Diagnostic, therapeutic and surgical patents, even if rarely granted, may negatively affect low-income patients’ access to required treatments, particularly in new areas such as gene-therapy59.

59 Though the gene therapy methods may not be patentable as such (if the suggested exclusion is provided for) the vectors and constructs that may be used could be patentable, as well as ex vivo process steps not involving the administration of the transformed cells to the patient (Grubb, 1999, p. 244).

In any case, the non-patentability of methods would not affect the patentability of equipments and substances necessary to execute them60.

60 In cases where the protection of such equipments and/or substances could lead to a de facto monopolization of the non-patented method, governments may have recourse to compulsory licenses, See Section X below.

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013